Retracted
This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
PMC · DOI:10.3389/fonc.2024.1383375·February 22, 2024
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHepatocellular Carcinoma Treatment and Prognosis · Cancer Mechanisms and Therapy · Liver physiology and pathology